Jones Financial Companies
SPRB

Jones Financial Companies’s Spruce Biosciences SPRB Stock Holding History

Jones Financial Companies’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65K Sell
30
-163
-84% -$9.11K ﹤0.01% 4484
2026
Q1 		$12.2K Buy
193
+109
+130% +$7.52K ﹤0.01% 3505
2025
Q4 		$7.32K Buy
+84
New +$9K ﹤0.01% 3358

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

Jones Financial Companies's SPRB Position: Q2 2026 in Review

Jones Financial Companies reduced its Spruce Biosciences (SPRB) stake by 84% in Q2 2026, selling an estimated $9.11K and leaving 30 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #4484.

Jones Financial Companies first reported a position in SPRB in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.2K in Q1 2026. 57 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Jones Financial Companies held 30 shares of Spruce Biosciences worth $1.65K as of Q2 2026.
  • Jones Financial Companies sold 163 Spruce Biosciences shares in Q2 2026, an estimated $9.11K.
  • Spruce Biosciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4484 holding.
  • Jones Financial Companies first reported a position in Spruce Biosciences in Q4 2025 and has held it in 3 quarters since.
  • Jones Financial Companies's Spruce Biosciences position peaked at $12.2K in Q1 2026.
  • 57 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.